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In this study, betathromboglobulin (BTG) and fibrinopeptide A (FPA) in peripheral venous blood were
measured in 20 patients with stable angina pectoris before and immediately after exercise-induced myocardial
ischaemia; in 5 of the 20 patients stable angina was associated with typical peripheral artery disease. A total of
10 patients with angiographically documented peripheral artery disease without angina and 10 normal volun-
teers were taken as control groups. BTG and FPA in the 15 patients with stable angina before exercise were
41 ±14 ng m/~' and 2-3 ± 09 ng ml'1 and were not statistically different from the values in normal controls;
after exercise-induced myocardial ischaemia no significant increase occurred in these patients. Conversely, in
the 5 patients with stable angina associated with peripheral artery disease BTG and FPA before exercise were
6l±10ngml~' and 3-5 ±0-8 ng ml'1 and increased to 114±14ngml'1 (P<0001) and4l ±0-5 ngml~'
(P < 001): These results were similar to those found in the 10 patients with isolated peripheral artery disease.
We conclude that BTG and FPA in peripheral venous blood in patients with stable angina are not elevated
either at rest or after exercise-induced myocardial ischaemia. Elevated values of BTG and FPA in patients with
stable angina may reflect a major interaction between blood and atherosclerotic vessel wall, suggesting the
presence of associated atherosclerotic lesions in peripheral artery disease.
Introduction ischaemia. Particular attention was paid to the
Coronary thrombosis is often associated with P r e s e n c e of concomitant peripheral artery disease,
acute myocardial infarction1'"31 and with unstable Methods
angina'4 '. The measurement of betathromboglobu-
lin (BTG) and fibrinopeptide A (FPA) in plasma are PATIENTS
useful means of detecting enhanced platelet activa- A total of 20 male patients with stable angina
tion'5 ' and fibrin formation in v/W6-71. We recently pectoris were admitted to the study. Criteria for
reported that patients with unstable angina often admission were:
present with elevated BTG and FPA levels'8-91. ( ' ) presence of 3 vessel disease documented by cor-
Discordant results have, however, been reported onary angiogram performed within 6 months
in regard to whether enhanced platelet activation before the study;
and/or fibrin formation occur during exercise- (2) pathological exercise ECG defined as horizontal
induced myocardial ischaemia in patients with o r downsloping ST-depression of ^ 2 mm in a
stable angina'10"131. precordial or inferior lead;
In the present study BTG and FPA were (3) absence of treatment with anticoagulants or
measured in 20 patients with stable angina before platelet inhibitory agents within the preceding 3
and immediately after exercise-induced myocardial months before the study;
(4) absence of acute myocardial infarction, throm-
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12 December 1986 coagulation disorders (neoplasia, severe infection,
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without an increase in frequency or severity, absence
of chest pain at rest and absence of decrease in exer-
cise tolerance during the 3 months preceding the
study.
A total of 5 of the 20 patients complained of
concomitant typical claudication of a lower limb
associated with pathological ankle-arm pressure
gradient measured by Doppler (<0-5); in all the
remaining 15 patients the ankle-arm pressure
gradient was normal. Medication included beta-
blockers in 16 patients, long-acting nitrates in 14
patients and calcium blockers in 12 patients. A total
of 10 patients with severe peripheral artery disease
documented angiographically without angina and
10 normal volunteers were taken as control groups.
PLATELET AND COAGULATION TESTS
Blood samples were taken by careful venepunc-
ture through a 19 butterfly-needle immediately
before and after exercise. All collections were done
by the same investigator. For BTG measurements,
4-2 ml of blood was collected into Thrombotect
tubes (Abbott Laboratories, Chicago), placed im-
mediately on ice and centnfuged within one hour at
2500 rpm for 45 minutes at 4°C; BTG was measured
by radioimmunoassay'5'.
For the FPA measurements 4-5 ml blood was col-
lected into a plastic syringe containing 500 U of
heparin and 500 U of aprotionin dissolved in 0-5 ml
of physiologic saline.
The samples were centrifuged within one hour for
30 minutes at 2500 rpm at 4°C. The plasma was
stored at -25°C. FPA levels were measured by
radioimmunoassay in plasma from which fibrino-
gen had been absorbed by bentonite16'71.
EXERCISE PROTOCOL
In the 20 patients with coronary artery disease
and in the 10 controls, stress test exercise was per-
formed on a bicycle ergometer, using a modified
Bruce protocol. The ECG in V,, V5 and AVF leads
was monitored using a computer assisted system
(Marquette Case System). In patients with coron-
ary artery disease the stress test was interrupted
when the patient reported typical chest pain and
there was a horizontal or descending ST-segment
depression (60 ms after the J point) of at least 2 mm
in one of the monitored leads. The stress test in the
10 volunteers was interrupted at the moment of
reaching maximal heart rate (215 —age). In the 10
patients with isolated peripheral artery disease, the
stress test exercise was performed using a treadmill:
the stress test was interrupted when the patient
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Figure I BTG before and after exercise-induced myocardial
ischaemia in patients with stable angina without peripheral
artery disease.
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Figure 2 FPA before and after exercise-induced myocardial
ischaemia in patients with stable angina without peripheral
artery disease.
complained of severe typical claudication. None of
these patients had chest pain and/or pathological
ST-segment depression, Heart rate pressure product
(mmHg min~') at peak exercise in these patients
was 8±3-9x 103 and significantly lower than in
patients with CAD (16 ± 4 1 x 103) (/><001).
The paired /-test was used for comparison of the
BTG and FPA values before and after exercise. The
Student /-test was used for comparison of the heart
rate-pressure products.
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Results
PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
AND WITHOUT PERIPHERAL ARTERY DISEASE (PAD)
In the 15 patients with CAD but without PAD,
BTG and FPA levels in plasma at rest were
41 ± 14ngml~' and 2-3±0-9 ng ml"1, respectively
and were slightly but not significantly elevated
when compared to the values in normal controls
(Table 2). Immediately after exercise-induced myo-
cardial ischemia there was neither a significant
increase of the BTG nor of the FPA level when
compared to the values at rest (Figs 1 and 2).
PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
ASSOCIATED WITH PERIPHERAL ARTERY DISEASE (PAD)
The levels of BTG and FPA at rest in the 5
patients with CAD and PAD were 61 ± 10 ng ml"1
and 3-5±0-8ng ml"1, respectively, and signifi-
cantly higher than in patients with CAD alone
(P < 001) as well as in the controls (P < 001). After
exercise-induced myocardial ischaemia BTG and
FPA increased up to 114±14ng ml"1 (P<00\)
and 41 ± 0-5 ng ml"1, respectively (P< 001).
Table I Clinical and haemodynamic data of the patients with
stable angina
N age (years) NYHA CAD
20 56± 10 2-2 20
PAD EF (%)
5 54±7
CAD (3 vd) = coronary artery disease with angiographically
documented 3-vessel disease
PA D = peripheral artery disease with typical claudication
and pathological ankle-arm pressure gradient (< 0-5)
EF = ejection fraction
PATIENTS WITH PERIPHERAL ARTERY DISEASE (PAD)
The levels of BTG and FPA in plasma at rest in
the 10 patients with PAD were 56 ± 14 ng ml" l and
3-7±l-2ng ml"1. Immediately after calf pain
limited exercise, levels of BTG and FPA increased
up to 127±31ngml" 1 ( / '<0001)and80±41 ng
ml"1 (P<001), respectively. BTG and FPA levels
in the 10 volunteers were 28±13ng ml"1 and
1-7 + 0-7 ng ml"1 and did not increase significantly
after maximal effort exercise (Table 1).
Discussion
Our results indicate that enhanced platelet acti-
vation and fibrin formation do not occur in peri-
pheral venous blood either at rest or immediately
after exercise-induced myocardial ischaemia in
patients with stable angina and severe coronary
artery disease. These findings confirm the previous
report of Marcella et a/.[131, but are in discrepancy
with the results of several other authors1'0"121, who
reported increased platelet activation in patients
with angina.
Since we recently demonstrated that patients
with severe peripheral artery disease often present
evidence of increased fibrin formation in v;W14' we
directed our attention to those patients with coron-
ary artery disease and stable angina associated with
clinical and haemodynamic signs of peripheral
artery disease. In fact, of the small group of patients
with angina associated with claudication all
patients presented enhanced levels of BTG and
FPA at rest and a further significant increase of
these variables after exercise-induced myocardial
ischaemia, reflecting the results of a control group
of patients with angiographically documented
severe peripheral artery disease (PAD). The absence
Table 2 BTG and FPA measurements (mean±SD) in patients with coronary artery disease (CAD) without and with peripheral
artery disease (PA D), in patients with PA D alone and in normal volunteers before and immediately after exercise
CAD
CAD + PAD
PAD
controls
AT
15
5
10
10
rest
41 ± 14
61 ± 10t
56±14f
28±12
BTG
exercise
42±I5
114±14»
I27±3I*
35±11
rest
2-3±0-9
3-5±O-8t
3-7±I-2f
l-7±0-7
FPA
exercise
2-4 ±0-9
41 ±0-5*
8-0±4-l*
l-8±0-7
*means P < 001 when compared to the corresponding values at rest
tmeans P < 0-05 when compared to the corresponding values in normal volunteers
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of angina and ST-segment depression in the
patients with PAD does not exclude the presence of
concomitant coronary artery disease (CAD). How-
ever, patients with severe CAD but without evi-
dence of PAD did not present enhanced platelet
activation and fibrin formation; whereas all
patients with CAD and associated PAD had elev-
ated BTG and FPA at rest and after exercise. Thus,
the controversial reports on platelet activation and/
or fibrin formation in patients with angina may be
explained by the presence or absence of patients
with peripheral artery disease or — as we previously
reported'81 — by the inclusion of patients with
unstable angina.
Platelet activation and fibrin formation may be
enhanced in the coronary circulation without evi-
dence in peripheral venous blood. Sampling of
blood in coronary sinus, though often challenged
because of artifactual activation due to the cardiac
catheters, may give an answer to this question. The
use of heparin bonded catheters may be a valid
means solving this problem'131.
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